1. The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine
   Tyler C. Beck et al, 2020, Frontiers in Pharmacology CrossRef
2. The Implications of Zinc Therapy in Combating the COVID-19 Global Pandemic
   Nandeeta Samad et al, 2021, Journal of Inflammation Research CrossRef
3. From Innate Immunity to Inflammation: A Primer on Multiple Facets of NF-κB Signaling in COVID-19
   Ashutosh Pandey et al, 2022, Physiologia CrossRef
4. Artemisinins—a Promising New Treatment for Systemic Lupus Erythematosus: a Descriptive Review
   Xiaozhen Mu et al, 2018, Current Rheumatology Reports CrossRef
5. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm
   Paulina Niedźwiedzka-Rystwej et al, 2022, International Journal of Molecular Sciences CrossRef
6. Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?
   Njundu Jatta et al, 2023, Clinical and Experimental Medicine CrossRef
7. Bibliometric and visual analysis of cardiovascular diseases and COVID-19 research
   Namin Wei et al, 2022, Frontiers in Public Health CrossRef
8. The Therapeutic Effect of Artemisinin and Its Derivatives in Kidney Disease
   Ming Xia et al, 2020, Frontiers in Pharmacology CrossRef
9. Therapeutic potential of artemisinin and its derivatives in managing kidney diseases
   Qi Jin et al, 2023, Frontiers in Pharmacology CrossRef
10. A Rare Case of Didanosine-Induced Mid-Peripheral Chorioretinal Atrophy Identified Incidentally 11 Years after the Drug Cessation
    Heba Joharjy et al, 2022, Medicina CrossRef